期刊文献+

在体3.0TMR波谱的肝脏脂质含量多元线性逐步回归模型 被引量:3

Multiple linear stepwise regression of fiver lipid levels: proton MR spectroscopy study in vivo at 3.0 T
原文传递
导出
摘要 目的 采用在体3.0 T MRS方法筛选出影响肝脏脂质沉积的重要因素并建立回归预测方程.方法 正常及弥漫性脂肪肝志愿者共44名,记录身高、年龄、体质量及体质量指数(BMI),采用3.0 T超导MR扫描仪,8通道腹部相控阵线圈,行单体素点分辨波谱分析法序列采集.采集前行常规预扫描,记录线宽(LW)及抑水率(WS),所获谱线采用后处理软件分析.以水为内参照,对肝脏的脂肪含量进行标准化,定义为脂(%)=脂/(脂+水)×100%.对身高、体质量、年龄、BMI、LW、WS和肝脏标准化脂质含量采用Person方法进行相关分析,以肝脏中脂质含量为因变量进行多元线性回归,采用逐步回归方法建立预测方程.结果 受试者肝脏脂质含量(0.00~0.96%,中位数为0.02%)与年龄[(39.1±12.6)岁]、体质量[(64.4±10.4)kg]、BMI(23.3±3.1)、LW(18.9±4.4)及WS[(90.7±6.5)%]5个因素的表达有相关性(r值分别为0.11、0.44、0.40、0.52和-0.73,P值均〈0.05),只有年龄、BMI、LW及WS进入多元线性回归方程.预测方程标准化脂质含量(Y)=1.395-(0.021×WS)+(0.022×BMI)+(0.014×LW)-(0.004×年龄),决定系数为0.61,校正决定系数为0.59.结论 该回归模型拟合较好,自变量年龄、BMI、LW及WS能够解释约60%肝脏脂质含量的变化. Objective To analyze the correlations between liver lipid level determined by liver 3.0 T 1H-MRS in vivo and influencing factors using multiple linear stepwise regression. Methods The prospective study of liver 1H-MRS was performed with 3.0 T system and eight-channel torso phased-array coils using PRESS sequence. Forty-four volunteers were enrolled in this study. Liver spectra were collected with a TR of 1500 ms ,TE of 30 ms, volume of interest of 2 cm ×2 cm ×2 cm, NSA of 64 times. The acquired raw proton MRS data were processed by using a software program SAGE. For each MRS measurement, using water as the internal reference, the amplitude of the lipid signal was normalized to the sum of the signal from lipid and water to obtain percentage lipid within the liver. The statistical description of height, weight, age and BMI, Line width and water suppression were recorded, and Pearson analysis was applied to test their relationships. Multiple linear stepwise regression was used to set the statistical model for the prediction of Liver lipid content. Results Age (39.1 ± 12. 6) years, body weight (64.4 ± 10. 4) kg,BMI (23.3 ±3.1) kg/m2, linewidth (18.9 ±4.4) and the water suppression (90.7 ±6.5)% had significant correlation with liver lipid content (0.00 to 0.96%, median 0. 02% ), r were 0.11,0. 44,0. 40,0. 52, - 0. 73 respectively(P 〈 0. 05 ). But only age, BMI, line width, and the water suppression entered into the multiple linear regression equation. Liver lipid content prediction equation was as follows: Y =1.395-(0.021 × water suppression) + (0.022 × BMI) + (0.014 × line width) - ( 0. 064 × age),and the coefficient of determination was 0.613, corrected coefficient of determination was 0.59. Conclusion The regression model fitted well, since the variables of age, BMI, width, and water suppression can explain about 60% of liver lipid content changes.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2010年第9期954-957,共4页 Chinese Journal of Radiology
基金 基金项目:国家自然科学基金资助项目(30800269) 广东省科技计划基金资助项目(200581040104020078031515008) 广东省自然科学基金资助项目(5001199)
关键词 磁共振波谱学 Liver Magnetic resonance spectroscopy
  • 相关文献

参考文献3

二级参考文献16

  • 1范明霞,田建明,陆建平.肝脏病变活体MR波谱研究进展[J].中华放射学杂志,2004,38(7):771-773. 被引量:11
  • 2白亮彩,郭顺林,周怀琪,雷军强,窦郁,张毅.1H MRS在定量分析脂肪肝中的初步研究[J].中国医学影像技术,2006,22(4):529-531. 被引量:27
  • 3Bin Wu,Wei-jun Peng,Pei-jun Wang,Ya-jia Gu,Wen-tao Li,Liang-pin Zhou,Feng Tang,Guo-ming Zhong.IN VIVO ~1 H MAGNETIC RESONANCE SPECTROSCOPY IN EVALUATION OF HEPATOCELLULAR CARCINOMA AND ITS EARLY RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION[J].Chinese Medical Sciences Journal,2006,21(4):258-264. 被引量:22
  • 4吴坚,叶慧义,孙非,张静,梁燕,马林,蔡幼铨,杨立.肝细胞癌3.0TMR氢质子波谱的初步研究[J].中国医学影像技术,2006,22(12):1856-1859. 被引量:17
  • 5Takeyoshi Imaeda M.D.,Yoshiharu Yamawaki,Matsuzo Seki,Hiroo Goto,Gen Iinuma,Masayuki Kanematsu,Ryozo Mochizuki,Hidetaka Doi,Shigetoyo Saji,Kuniyasu Shimokawa.Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: Correlation between computed tomography and histopathology[J].Cardiovascular and Interventional Radiology.1993(4)
  • 6Jagannathan NR,KumarM,Seenu V, et al.Evaluation of total choline fromin-vivovolume localized proton MR spectroscopy and its response to neoadjuvantchemotherapy in locally advanced breast cancer[].British Journal of Cancer.2001
  • 7Llovet JM,Real MI,Montana X, et al.Arterial embolisation or chemoembolisationversussymptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial[].The Lancet.2002
  • 8Longo R,Ricci C,Masutti F, et al.Fatty infiltration of the liv- er Quantification by1H localized magnetic resonance spectros- copy and comparison with computed tomography[].Invest Raiol.1993
  • 9Cho SG,Kim MY,Kim HJ, et al.Chronic hepatitis:in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings[].Radiology.2001
  • 10Castillo M,,Kwock L,Mukherji SK.Clinical applications of proton MR spectroscopy[].American Journal of Neuroradiology.1996

共引文献34

同被引文献31

  • 1颜红梅,高鑫,刘蒙,顾迁,张斌,李湘,高键,赵耐青.非酒精性脂肪肝与代谢综合征关系的研究[J].中国糖尿病杂志,2006,14(5):326-328. 被引量:74
  • 2颜红梅,高鑫,刘蒙,顾迁,高键.糖调节正常的非酒精性脂肪肝病患者β细胞功能与胰岛素敏感性变化[J].中华内分泌代谢杂志,2007,23(1):12-15. 被引量:13
  • 3张静,程流泉,叶慧义,蔡幼铨,马林,孙非,郭行高.正常肝脏3.0T质子MRS的定量研究[J].中国医学影像技术,2007,23(8):1191-1193. 被引量:11
  • 4Yki-Jarvinen H. Fat in the liver and insulin resistance [ J ]. Ann Med ,2005,37:347-356.
  • 5Kotronen A, Westerbacka J, Bergholm R, et al. Liver fat in the meta- bolic syndrome [ J ]. J Clin Endocrinol Metab,2007,92 : 3490-3497.
  • 6Sattar N, McConnachie A, Ford I, et al. Serial metabolic measure- ments and conversion to type 2 diabetes in the west of Scotland coro- nary prevention study: specific elevations in alanine aminotrans- ferase and triglycerides suggest hepatic fat accunmlation as a poten- tial contributing factor[ J]. Diabetes,2007,56:984-991.
  • 7Strang BD,Bertics SJ, Grummer RR, et al. Relationship of triglycer- ide accumulation to insulin clearance and hormonal responsiveness in bovine hepatocytes [ J ]. J Dairy Sci, 1998,81:740-747.
  • 8Wylezinska M, Cobbold JF, Fitzpatrick J, et al. A comparison of sin- gle-voxel clinical in vivo hepatic 31 P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states [ J ]. NMR Biomed, 2011,24:231-237.
  • 9Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population[ J]. Am J Physiol Endo- crinol Metab ,2005,288:462-468.
  • 10Mebta SR,Thomas EL, Bell JD,et al. Noninvasive means of measur- ing hepatic fat content [ J ]. World J Gastroenterol, 2008,14 : 3476- 3483.

引证文献3

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部